Skip to content

Abbott Architect Folate

by Abbott Laboratories 510(k)

Active United States

510(k) K984301

Overview

The Abbott Architect Folate is a Chemiluminescent Microparticle Folate Binding Protein assay for the quantitative determination of folate in human serum, plasma, and red blood cells on the Abbott Architect i System. Measurements obtained by this device aid in the diagnosis and treatment of megaloblastic anemia.

The device is supplied as a Class II medical device with product code CGN, classified as Acid, Folic, Radioimmunoassay. It received FDA 510(k) clearance with number K984301 on February 5, 1999, after being submitted by Abbott Laboratories. The device is intended for use in clinical chemistry settings for quantitative folate measurement.

AI-generated from registry data, 25 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK984301 Date5 Feb 1999ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 6 Oct 2026)

Specification

510(k)

510(k) Number
FDA Product Code
CGN
Device Class
Class II
Regulation
21 CFR Part 862.1295
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Questions

  • What is the Abbott Architect Folate assay used for?

    The Abbott Architect Folate is a chemiluminescent microparticle assay used for the quantitative determination of folate in human serum, plasma, and red blood cells. It aids in the diagnosis and treatment of megaloblastic anemia.

  • How is the Abbott Architect Folate assay supplied?

    The device is supplied as a Class II medical device with product code CGN, classified as Acid, Folic, Radioimmunoassay. It is intended for use in clinical chemistry settings for quantitative folate measurement.

  • What is the regulatory status of the Abbott Architect Folate assay?

    The Abbott Architect Folate received FDA 510(k) clearance with number K984301 on February 5, 1999, after being submitted by Abbott Laboratories. It was determined to be substantially equivalent to predicate devices.

  • What samples can be used with the Abbott Architect Folate assay?

    The Abbott Architect Folate assay can be used with human serum, plasma, and red blood samples for quantitative folate measurement, making it suitable for various clinical testing scenarios.